Search - tctmd.com

Displaying 781 - 800 of 2992

Sort: Relevancy | Date

Presentation TCT 2019

Root Causes of Thrombosis and Restenosis With Contemporary Metallic DES: Intravascular Imaging Insights

Presenter: Giulio Guagliumi

September 27, 2019

Presentation TCT 2019

Root Causes of Thrombosis and Restenosis With Contemporary Metallic DES: Pathologic Insights

Presenter: Aloke Finn

September 27, 2019

Presentation TCT 2019

PROTECT III First Look: High-Risk PCI Outcomes in 800 Impella-Supported Patients

Presenter: Jeffrey Popma

September 27, 2019

Presentation TCT 2019

Elective High-Risk PCI and Hemodynamic Support: Evidence-Based and Experience-Based Recommendations

Presenter: Divaka Perera

September 27, 2019

Presentation TCT 2019

PCI vs. CABG in Multivessel Disease (With and Without Diabetes): Latest Clinical Trial Data

Presenter: Sripal Bangalore

September 27, 2019

Presentation TCT 2019

Preview From the Upcoming Ischemia Trial

Presenter: David Maron

September 27, 2019

Presentation TCT 2019

Revascularization in Stable CAD: What Do the New 2019 ESC Guidelines Recommend?

Presenter: Jean Fajadet

September 27, 2019

Presentation TCT 2019

Clinical Trial Design in HBR Patients: Should Risk Scores Be Incoporated?

Presenter: Davide Capodanno

September 27, 2019

Presentation TCT 2019

Does Stent Design Make a Difference in Treating LM Bifurcation Lesions?

Presenter: Fazila Malik

September 27, 2019

Presentation TCT 2019

Potential Study Designs to Address the Mortality Safety Signal

Presenter: Laura Mauri

September 26, 2019

Presentation TCT 2019

Study Design Considerations for HBR Patients in Japan

Presenter: Yasuko Nakamura

September 26, 2019

Presentation TCT 2019

Study Design Considerations for HBR Patients and DES Platforms: FDA View

Presenter: Adrian Magee

September 26, 2019

News Conference News TCT 2019

Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT

Caitlin E. Cox

September 26, 2019

Presentation TCT 2019

Clinical Trial Design Considerations for Next-to-Market and Next-Generation LAAO Devices

Presenter: Brian Whisenant

September 26, 2019

Presentation TCT 2019

Ultrathin Orsiro: Where It Can Go

Presenter: Steven Yakubov

September 26, 2019

Presentation TCT 2019

FDA Pivotal Clinical Trial Design and Beyond

Presenter: Ori Ben-Yehuda

September 26, 2019

Presentation TCT 2019

Use of Sirolimus-Coated Balloon (MagicTouch) in Coronary Intervention: Data and Case Examples From a Real-World Population

Presenter: Sandeep Basavarajaiah

September 26, 2019

Presentation TCT 2019

A Personal Perspective: Why I Choose Orsiro in STEMI

Presenter: Juan Fernando Iglesias

September 26, 2019

News TCT 2019

TCT 2019 Day One: TWILIGHT and Onyx ONE Kick Things Off

Shelley Wood

September 26, 2019

Presentation TCT 2019

Real-World Data From EASTBOURNE to TRANSFORM Trials

Presenter: Bernardo Cortese

September 26, 2019

Advertisement

Root Causes of Thrombosis and Restenosis With Contemporary Metallic DES: Intravascular Imaging Insights

Root Causes of Thrombosis and Restenosis With Contemporary Metallic DES: Pathologic Insights

PROTECT III First Look: High-Risk PCI Outcomes in 800 Impella-Supported Patients

Elective High-Risk PCI and Hemodynamic Support: Evidence-Based and Experience-Based Recommendations

PCI vs. CABG in Multivessel Disease (With and Without Diabetes): Latest Clinical Trial Data

Preview From the Upcoming Ischemia Trial

Revascularization in Stable CAD: What Do the New 2019 ESC Guidelines Recommend?

Clinical Trial Design in HBR Patients: Should Risk Scores Be Incoporated?

Does Stent Design Make a Difference in Treating LM Bifurcation Lesions?

Potential Study Designs to Address the Mortality Safety Signal

Study Design Considerations for HBR Patients in Japan

Study Design Considerations for HBR Patients and DES Platforms: FDA View

Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT

Clinical Trial Design Considerations for Next-to-Market and Next-Generation LAAO Devices

Ultrathin Orsiro: Where It Can Go

FDA Pivotal Clinical Trial Design and Beyond

Use of Sirolimus-Coated Balloon (MagicTouch) in Coronary Intervention: Data and Case Examples From a Real-World Population

A Personal Perspective: Why I Choose Orsiro in STEMI

TCT 2019 Day One: TWILIGHT and Onyx ONE Kick Things Off

Real-World Data From EASTBOURNE to TRANSFORM Trials

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content